Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385487029> ?p ?o ?g. }
- W4385487029 abstract "Abstract mRNA vaccine technologies introduced following the SARS-CoV-2 pandemic have highlighted the need to better understand the interaction of adjuvants and the early innate immune response. Interferon type I (IFN-I) is an integral part of this early innate response and can prime several components of the adaptive immune response. Females are widely reported to respond better than males to seasonal tri- and quad-valent influenza vaccines. Plasmacytoid dendritic cells (pDCs) are the primary cell type responsible for IFN-I production and female pDCs produce more IFN-I than male pDCs since the upstream receptor TLR7 is encoded by the X-chromosome and is biallelically expressed by up to 30% of female immune cells. Additionally, the TLR7 promoter contains putative androgen response elements and androgens have been reported to suppress pDC IFN-I in-vitro . Unexpectedly, therefore, we recently observed that male adolescents mount stronger antibody responses to the Pfizer BNT162b2 mRNA vaccine than female adolescents after controlling for natural SARS-CoV-2 infection. We here examined pDC behaviour in this cohort to determine the impact of IFN-I on anti-Spike and anti-receptor-binding domain titres to BNT162b2. Through LASSO modelling we determined that serum free testosterone was associated with reduced pDC IFN-I but, contrary to the well-described immunosuppressive role for androgens, the more potent androgen dihydrotestosterone was associated with increased IgG titres to BNT162b2. Also unexpectedly, we observed that co-vaccination with live-attenuated influenza vaccine boosted the magnitude of IgG responses to BNT162b2. Together these data support a model where systemic IFN-I increased vaccine-mediated immune responses, but for vaccines with intracellular stages, modulation of the local IFN-I response may alter antigen longevity and consequently vaccine-driven immunity. Author Summary Type I interferons (IFN-I) are potent antiviral proteins which play a central role in activating the immune response and driving inflammation. IFN-I is predominantly produced by plasmacytoid dendritic cells (pDCs) and female pDCs produce more IFN-I than male pDCs. Consequently, females typically generate stronger antibody responses to vaccines such as seasonal influenza vaccines. In addition, females typically suffer more serious adverse events from vaccines. However, we recently reported in a study of adolescents that males generate stronger antibody responses to the SARS-CoV-2 mRNA vaccine BNT162b2 than females. Here we examine the IFN-I response of pDCs in adolescents co-/vaccinated with BNT162b2 and live-attenuated influenza vaccine (LAIV). We find that male sex hormones reduce pDC IFN-I but are associated with increased BNT162b2 antibody titres. We also observe that LAIV boosts BNT162b2 antibody titres through possible bystander activation of immune cells. These findings are consistent with a reportedly higher incidence of adverse events among males associated with this vaccine. Together these data suggest that IFN-I production typically enhances vaccine-specific immune responses but for new mRNA vaccines such as BNT162b2, that are modified to reduce innate immunogenicity, localised dampening of the IFN-I response in vaccinated tissue by male sex hormones may further delay the clearance of the vaccine, increasing vaccine antigen exposure and allowing time for a stronger antibody response." @default.
- W4385487029 created "2023-08-03" @default.
- W4385487029 creator A5004709847 @default.
- W4385487029 creator A5010324154 @default.
- W4385487029 creator A5018523831 @default.
- W4385487029 creator A5024961246 @default.
- W4385487029 creator A5026843217 @default.
- W4385487029 creator A5027299449 @default.
- W4385487029 creator A5029367587 @default.
- W4385487029 creator A5029546143 @default.
- W4385487029 creator A5032591855 @default.
- W4385487029 creator A5043346206 @default.
- W4385487029 creator A5044530527 @default.
- W4385487029 creator A5046971145 @default.
- W4385487029 creator A5052144215 @default.
- W4385487029 creator A5055969901 @default.
- W4385487029 creator A5071780846 @default.
- W4385487029 creator A5072084139 @default.
- W4385487029 creator A5079914158 @default.
- W4385487029 creator A5083579687 @default.
- W4385487029 creator A5089224585 @default.
- W4385487029 creator A5092582131 @default.
- W4385487029 date "2023-08-02" @default.
- W4385487029 modified "2023-09-27" @default.
- W4385487029 title "Gonadal androgens are associated with decreased type I interferon production by pDCs and increased IgG titres to BNT162b2 following co-vaccination with live attenuated influenza vaccine in adolescents" @default.
- W4385487029 cites W1772394217 @default.
- W4385487029 cites W2027798298 @default.
- W4385487029 cites W2049998759 @default.
- W4385487029 cites W2054877457 @default.
- W4385487029 cites W2056549743 @default.
- W4385487029 cites W2059980695 @default.
- W4385487029 cites W2076092191 @default.
- W4385487029 cites W2098597036 @default.
- W4385487029 cites W2118306668 @default.
- W4385487029 cites W2126339385 @default.
- W4385487029 cites W2131643987 @default.
- W4385487029 cites W2134231495 @default.
- W4385487029 cites W2135046866 @default.
- W4385487029 cites W2137781960 @default.
- W4385487029 cites W2139751280 @default.
- W4385487029 cites W2147146850 @default.
- W4385487029 cites W2162970812 @default.
- W4385487029 cites W2236650526 @default.
- W4385487029 cites W2486559230 @default.
- W4385487029 cites W2518536270 @default.
- W4385487029 cites W2559341989 @default.
- W4385487029 cites W2609522512 @default.
- W4385487029 cites W2752706152 @default.
- W4385487029 cites W2756483320 @default.
- W4385487029 cites W2756945639 @default.
- W4385487029 cites W2782708334 @default.
- W4385487029 cites W2988372882 @default.
- W4385487029 cites W3110901620 @default.
- W4385487029 cites W3113774549 @default.
- W4385487029 cites W3133745688 @default.
- W4385487029 cites W3133848474 @default.
- W4385487029 cites W3140429722 @default.
- W4385487029 cites W3144140615 @default.
- W4385487029 cites W3155262144 @default.
- W4385487029 cites W3182898074 @default.
- W4385487029 cites W3183801203 @default.
- W4385487029 cites W3198331993 @default.
- W4385487029 cites W3198715031 @default.
- W4385487029 cites W3206717788 @default.
- W4385487029 cites W3210401977 @default.
- W4385487029 cites W4206899236 @default.
- W4385487029 cites W4220947557 @default.
- W4385487029 cites W4220978613 @default.
- W4385487029 cites W4230202275 @default.
- W4385487029 cites W4288724425 @default.
- W4385487029 cites W4290785545 @default.
- W4385487029 cites W4313483818 @default.
- W4385487029 cites W4385296679 @default.
- W4385487029 doi "https://doi.org/10.1101/2023.08.01.551423" @default.
- W4385487029 hasPublicationYear "2023" @default.
- W4385487029 type Work @default.
- W4385487029 citedByCount "0" @default.
- W4385487029 crossrefType "posted-content" @default.
- W4385487029 hasAuthorship W4385487029A5004709847 @default.
- W4385487029 hasAuthorship W4385487029A5010324154 @default.
- W4385487029 hasAuthorship W4385487029A5018523831 @default.
- W4385487029 hasAuthorship W4385487029A5024961246 @default.
- W4385487029 hasAuthorship W4385487029A5026843217 @default.
- W4385487029 hasAuthorship W4385487029A5027299449 @default.
- W4385487029 hasAuthorship W4385487029A5029367587 @default.
- W4385487029 hasAuthorship W4385487029A5029546143 @default.
- W4385487029 hasAuthorship W4385487029A5032591855 @default.
- W4385487029 hasAuthorship W4385487029A5043346206 @default.
- W4385487029 hasAuthorship W4385487029A5044530527 @default.
- W4385487029 hasAuthorship W4385487029A5046971145 @default.
- W4385487029 hasAuthorship W4385487029A5052144215 @default.
- W4385487029 hasAuthorship W4385487029A5055969901 @default.
- W4385487029 hasAuthorship W4385487029A5071780846 @default.
- W4385487029 hasAuthorship W4385487029A5072084139 @default.
- W4385487029 hasAuthorship W4385487029A5079914158 @default.
- W4385487029 hasAuthorship W4385487029A5083579687 @default.
- W4385487029 hasAuthorship W4385487029A5089224585 @default.
- W4385487029 hasAuthorship W4385487029A5092582131 @default.
- W4385487029 hasBestOaLocation W43854870291 @default.
- W4385487029 hasConcept C134018914 @default.